In breast cancer, the stability and expression of METTL14 are positively regulated by LNC942, which elevates the m6A content in downstream targets CXCR4 and CYP1B1, stabilizes protein expression and translation, and further promotes tumorigenesis.49 This evidence concerns the gene METTL14 and breast cancer.